Chai Discovery builds frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules. They are developing foundation models for biology and drug discovery to transform how biopharma creates new therapies.
- Category
- AI Drug Discovery
- Stage
- Series B
- Employees
- 29
- HQ
- San Francisco, United States
- Founded
- 2024
- Funding
- $230M